Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Change in Account Payables: 2013-2024

Historic Change in Account Payables for Assembly Biosciences (ASMB) over the last 12 years, with Dec 2024 value amounting to $124,000.

  • Assembly Biosciences' Change in Account Payables rose 76.03% to $940,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $348,000, marking a year-over-year decrease of 39.69%. This contributed to the annual value of $124,000 for FY2024, which is 106.10% up from last year.
  • As of FY2024, Assembly Biosciences' Change in Account Payables stood at $124,000, which was up 106.10% from -$2.0 million recorded in FY2023.
  • In the past 5 years, Assembly Biosciences' Change in Account Payables ranged from a high of $2.9 million in FY2020 and a low of -$2.0 million during FY2023.
  • For the 3-year period, Assembly Biosciences' Change in Account Payables averaged around -$691,333, with its median value being -$166,000 (2022).
  • Per our database at Business Quant, Assembly Biosciences' Change in Account Payables skyrocketed by 246.13% in 2020 and then tumbled by 1,124.10% in 2023.
  • Over the past 5 years, Assembly Biosciences' Change in Account Payables (Yearly) stood at $2.9 million in 2020, then slumped by 167.63% to -$1.9 million in 2021, then surged by 91.44% to -$166,000 in 2022, then tumbled by 1,124.10% to -$2.0 million in 2023, then surged by 106.10% to $124,000 in 2024.